• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AMPA 受体神经传递及其治疗应用:对其多方面调制的综合综述。

AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation.

机构信息

Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

出版信息

Eur J Med Chem. 2024 Feb 15;266:116151. doi: 10.1016/j.ejmech.2024.116151. Epub 2024 Jan 14.

DOI:10.1016/j.ejmech.2024.116151
PMID:38237342
Abstract

The neuropharmacological community has shown a strong interest in AMPA receptors as critical components of excitatory synaptic transmission during the last fifteen years. AMPA receptors, members of the ionotropic glutamate receptor family, allow rapid excitatory neurotransmission in the brain. AMPA receptors, which are permeable to sodium and potassium ions, manage the bulk of the brain's rapid synaptic communications. This study thoroughly examines the recent developments in AMPA receptor regulation, focusing on a shift from single chemical illustrations to a more extensive investigation of underlying processes. The complex interplay of these modulators in modifying the function and structure of AMPA receptors is the main focus, providing insight into their influence on the speed of excitatory neurotransmission. This research emphasizes the potential of AMPA receptor modulation as a therapy for various neurological disorders such as epilepsy and Alzheimer's disease. Analyzing these regulators' sophisticated molecular details enhances our comprehension of neuropharmacology, representing a significant advancement in using AMPA receptors for treating intricate neurological conditions.

摘要

在过去的十五年中,神经药理学领域对 AMPA 受体表现出了浓厚的兴趣,将其视为兴奋性突触传递的关键组成部分。AMPA 受体是离子型谷氨酸受体家族的成员,允许大脑中快速的兴奋性神经传递。AMPA 受体对钠离子和钾离子具有通透性,管理着大脑中大部分快速的突触通讯。本研究全面考察了 AMPA 受体调节的最新进展,重点关注从单一化学描述向更广泛的基础过程研究的转变。这些调节剂在调节 AMPA 受体功能和结构方面的复杂相互作用是主要关注点,深入了解它们对兴奋性神经传递速度的影响。这项研究强调了 AMPA 受体调节作为治疗各种神经障碍(如癫痫和阿尔茨海默病)的潜在疗法。分析这些调节剂的复杂分子细节,增强了我们对神经药理学的理解,代表着在使用 AMPA 受体治疗复杂神经疾病方面的重大进展。

相似文献

1
AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation.AMPA 受体神经传递及其治疗应用:对其多方面调制的综合综述。
Eur J Med Chem. 2024 Feb 15;266:116151. doi: 10.1016/j.ejmech.2024.116151. Epub 2024 Jan 14.
2
AMPA Receptors as Therapeutic Targets for Neurological Disorders.AMPA受体作为神经疾病的治疗靶点
Adv Protein Chem Struct Biol. 2016;103:203-61. doi: 10.1016/bs.apcsb.2015.10.004. Epub 2015 Nov 19.
3
Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.AMPA/红藻氨酸受体配体的药理学及其在神经和精神疾病中的治疗潜力。
Drugs. 2000 Jan;59(1):33-78. doi: 10.2165/00003495-200059010-00004.
4
Interacting partners of AMPA-type glutamate receptors.AMPA 型谷氨酸受体的相互作用伙伴。
J Mol Neurosci. 2012 Oct;48(2):441-7. doi: 10.1007/s12031-012-9724-6. Epub 2012 Feb 24.
5
Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?调节兴奋性突触神经传递:神经系统疾病的潜在治疗方法?
Neurobiol Dis. 1998 Aug;5(2):67-80. doi: 10.1006/nbdi.1998.0190.
6
Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.谷氨酸AMPA受体正变构调节剂的评估方法。
Methods Mol Biol. 2007;403:37-57. doi: 10.1007/978-1-59745-529-9_3.
7
Recent advances in positive allosteric modulators of the AMPA receptor.AMPA受体正变构调节剂的最新进展。
Curr Opin Drug Discov Devel. 2006 Sep;9(5):571-9.
8
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.神经疾病中的谷氨酸受体抗体:抗AMPA - GluR3抗体、抗NMDA - NR1抗体、抗NMDA - NR2A/B抗体、抗mGluR1抗体或抗mGluR5抗体存在于以下疾病患者的亚组中:癫痫、脑炎、小脑共济失调、系统性红斑狼疮(SLE)和神经精神性SLE、干燥综合征、精神分裂症、躁狂症或中风。这些自身免疫性抗谷氨酸受体抗体可在少数脑区与神经元结合,激活谷氨酸受体,降低谷氨酸受体的表达,损害谷氨酸诱导的信号传导和功能,激活血脑屏障内皮细胞,杀死神经元,损伤大脑,在动物模型中诱发行为/精神/认知异常和共济失调,并且在一些患者中可通过免疫疗法去除或使其失活。
J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1.
9
Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents.新型 AMPA 受体正变构调节剂(PAM)-43 的特性研究:配体的特异性结合及其增强 AMPAR 电流的能力。
Curr Mol Pharmacol. 2020;13(3):216-223. doi: 10.2174/1874467213666200303140834.
10
[Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].[AMPA型谷氨酸受体的变构调节剂:一类新型生理活性物质]
Biomed Khim. 2004;50(6):523-38.

引用本文的文献

1
Glutamate-Mediated Neural Alterations in Lead Exposure: Mechanisms, Pathways, and Phenotypes.铅暴露中谷氨酸介导的神经改变:机制、途径和表型
Toxics. 2025 Jun 21;13(7):519. doi: 10.3390/toxics13070519.
2
Regulating AMPA Receptors with Isoxazole-4-Carboxamide Derivatives: An Electrophysiological Study.用异恶唑-4-甲酰胺衍生物调节AMPA受体:一项电生理学研究。
J Xenobiot. 2025 Mar 8;15(2):40. doi: 10.3390/jox15020040.
3
Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study.
黄腐酚可预防 APP/PS1 小鼠的神经元兴奋性毒性和线粒体功能障碍:基于组学的研究。
Nutrients. 2024 Oct 31;16(21):3754. doi: 10.3390/nu16213754.
4
Nanoscale organization is changed in native, surface AMPARs by mouse brain region and tauopathy.在天然的、位于表面的α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPARs)中,纳米级组织会因小鼠脑区和tau蛋白病而发生改变。
bioRxiv. 2024 Jul 23:2024.07.22.604547. doi: 10.1101/2024.07.22.604547.
5
Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent.评估噻唑甲酰胺衍生物对 AMPA 受体复合物生物物理特性的影响,作为一种潜在的神经保护剂。
Molecules. 2024 Jul 8;29(13):3232. doi: 10.3390/molecules29133232.
6
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences.抑郁症中的代谢组学:我们从临床前和临床证据中学到了什么。
Mol Neurobiol. 2025 Jan;62(1):718-741. doi: 10.1007/s12035-024-04302-5. Epub 2024 Jun 19.